1N5O
Structural consequences of a cancer-causing BRCA1-BRCT missense mutation
Summary for 1N5O
Entry DOI | 10.2210/pdb1n5o/pdb |
Related | 1jnx |
Descriptor | Breast cancer type 1 susceptibility protein, COBALT (II) ION, SULFATE ION, ... (4 entities in total) |
Functional Keywords | brca1, brct, missense mutation, protein folding, breast cancer, antitumor protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 24808.29 |
Authors | Williams, R.S.,Glover, J.N.M. (deposition date: 2002-11-06, release date: 2002-12-25, Last modification date: 2024-02-14) |
Primary citation | Williams, R.S.,Glover, J.N.M. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation J.Biol.Chem., 278:2630-2635, 2003 Cited by PubMed Abstract: The integrity of the carboxyl-terminal BRCT repeat region is critical for BRCA1 tumor suppressor function; however, the molecular details of how a number of clinically derived BRCT missense mutations affect BRCA1 function remain largely unknown. Here we assess the structural response of the BRCT tandem repeat domain to a well characterized, cancer-associated single amino acid substitution, Met-1775 --> Arg-1775. The structure of BRCT-M1775R reveals that the mutated side chain is extruded from the protein hydrophobic core, thereby altering the protein surface. Charge-charge repulsion, rearrangement of the hydrophobic core, and disruption of the native hydrogen bonding network at the interface between the two BRCT repeats contribute to the conformational instability of BRCT-M1775R. Destabilization and global unfolding of the mutated BRCT domain at physiological temperatures explain the pleiotropic molecular and genetic defects associated with the BRCA1-M1775R protein. PubMed: 12427738DOI: 10.1074/jbc.M210019200 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.8 Å) |
Structure validation
Download full validation report
